Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

JPMorgan shares fall after Dimon disclosure of cancer

Published 07/02/2014, 12:04 PM
Updated 07/02/2014, 11:56 AM
JPMorgan shares fall after Dimon disclosure of cancer

NEW YORK (Reuters) - JPMorgan Chase & Co's shares fell as much as 1.3 percent Wednesday after Chairman and Chief Executive Jamie Dimon said late Tuesday he had been diagnosed with throat cancer.

The condition is curable, Dimon said in a memo to shareholders and employees, and he will undergo radiation and chemotherapy treatment for about eight weeks.

During that time, Dimon said his business travel would be limited but he would "be able to continue to be actively involved in our business."

JPMorgan's shares fell the most of any of the 24 stocks in the KBW index of bank stocks. The stock was down more than 1 percent at $56.90 in midday trading.

Rafferty Capital Markets bank analyst Dick Bove said in a report Wednesday Dimon was unlikely to retain his chairman title when he returns from treatment, and would likely spread more of his daily duties among other executives at the bank.

"JPMorgan Chase simply cannot present itself to the world as if it were a one-man show," Bove wrote.

Sources have previously said the bank has many senior executives who could step into Dimon's role if needed.

Potential internal successors include the head of the corporate and investment bank, Daniel Pinto; chief operating officer, Matt Zames; consumer banking head, Gordon Smith and asset management chief, Mary Erdoes. The bank has a short-, medium- and long-term succession plan in place, a source told Reuters on Tuesday.

JPMorgan lead director Lee Raymond said at the bank's shareholder meeting in May last year that the board intended to have a viable successor to Dimon but he hoped Dimon would stay at JPMorgan far into the future.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"I have no illusions that we will be able to clone Jamie," Raymond said at the time.

According to the National Cancer Institute, the survival rate for mouth and throat cancers diagnosed at any stage is 63 percent after five years. "I feel very good now and will let all of you know if my health situation changes," Dimon said in his memo.

Dimon has been JPMorgan's chief executive since 2006. He arrived at the bank via its 2004 merger with Bank One Corporation, where he had been chairman and CEO.

(Reporting by Peter Rudegeair; Editing by Bernadette Baum)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.